Betsy Plimack discusses the updated data with a minimum of 23 months’ follow up. Drs. Brian Rini and Tom Powles asks what it adds.
The Uromigos Episode 30: Update on Axitinib Plus Pembrolizumab in Renal Cancer (KEYNOTE 426)
By The Uromigos - Last Updated: September 21, 2022
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.